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INTRODUCTION
THE PREVALENCE OF DIABETES is increasing in the UnitedStates and now afflicts over 18 million individuals (2),
imposing a major challenge for the prevention and treatment
of chronic microvascular complications. Although the etiol-
ogy of the chronic complications is not well understood, re-
cent evidence clearly implicates increased oxidative stress
(8, 22, 50, 82) coupled with impaired antioxidant defense
(7, 21). In diabetic rodents, for example, increased oxidative
stress has been identified in the nerve (5, 22, 82), eye (65),
kidney (3), vasculature (41), and heart (34), and antioxidant
therapy can attenuate diabetes-induced deficits in these
tissues (64).
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ABSTRACT
In diabetes, overexpression of aldose reductase (AR) and consequent glucose-induced impairment of antioxi-
dant defense systems may predispose to oxidative stress and the development of diabetic complications, but
the mechanisms are poorly understood. Taurine (2-aminoethanesulfonic acid) functions as an antioxidant, os-
molyte, and calcium modulator such that its intracellular depletion could promote cytotoxicity in diabetes.
The relationships of oxidative stress and basal AR gene expression to Na+-taurine cotransporter (TT) gene ex-
pression, protein abundance, and TT activity were therefore explored in low AR-expressing human retinal
pigment epithelial (RPE) 47 cells and RPE 47 cells stably transformed to overexpress AR (RPE 75). Changes
in TT gene expression were determined using a 4.6-kb TT promoter-luciferase fusion gene. Compared with
RPE 47 cells, in high AR-expressing RPE 75 cells, TT promoter activity was decreased by 46%, which was
prevented by an AR inhibitor. TT promoter activity increased up to 900% by prooxidant exposure, which was
associated with increased TT peptide abundance and taurine transport. However, induction of TT promoter
activity by oxidative stress was attenuated in high AR-expressing cells and partially corrected by AR inhibitor.
Finally, exposure of RPE 75 cells to high glucose increased oxidative stress, but down-regulated TT expres-
sion. These studies demonstrate for the first time that the TT is regulated by oxidative stress and that overex-
pression of AR and high glucose impair this response. Abnormal expression of AR may therefore impair an-
tioxidant defense, which may determine tissue susceptibility to chronic diabetic complications. Antioxid. Redox
Signal. 7, 1530–1542.
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In diabetes, activation of aldose reductase (AR) has been
viewed as a critical link between hyperglycemia, intracellular
osmotic stress, oxidative stress, and tissue damage (38, 79).
AR-mediated oxidative stress is multifactorial, mediated by
shifts toward more oxidized state of NADP+/NADPH and
GSH/GSSG redox couples and by causing the compensatory
depletion of the osmolyte and endogenous antioxidant taurine
(48, 78, 83). AR gene expression is induced by extracellular
hyperosmolality (4), an observation that led to the formula-
tion of a “compatible osmolyte hypothesis,” which argues that
nonionic osmotically active compounds, including sorbitol
and taurine, function as alternative organic intracellular os-
molytes responding coordinately to changes in external os-
molality (6). Osmotic stress alters the intracellular concentra-
tion of these alternative osmolytes by the induction or
suppression of the synthetic enzymes, e.g., AR in the case of
sorbitol (54, 77), or membrane transporters, e.g., Na+-taurine
cotransporter (TT) (84).
Isotonic hyperglycemia perturbs this osmoregulatory sys-
tem by promoting intracellular sorbitol accumulation by pro-
viding excess substrate for AR rather than by osmotic induc-
tion of its gene (81). This may result in transcriptional
down-regulation of other osmotically regulated genes, includ-
ing the TT (81), causing their intracellular depletion. Al-
though initially regarded as metabolically inert, these alterna-
tive organic osmolytes are now thought to have important
metabolic as well as osmoregulatory roles (64, 67). For exam-
ple, taurine functions as an important endogenous antioxidant
(23, 64, 65), calcium modulator (31, 45), neurotransmitter
(11), as well as osmolyte (6, 77, 81), such that its intracellular
depletion could promote chronic cytotoxicity in diabetes.
Taurine depletion has been identified in the sciatic nerve,
retina, and lens of diabetic rodents (62, 64, 65), and taurine
replacement attenuates oxidative stress (64) and its down-
stream consequences in these tissues (48, 60, 64, 66).
We have previously reported the use of stable lines of cul-
tured human retinal pigment epithelial (RPE) cells to explore
the regulation of osmosensitive genes in response to high glu-
cose and hypertonicity (27, 77, 80). RPE cell lines have been
identified that exhibit quantitative and qualitative differences
in AR gene regulation (27, 77). In these cells, the antiparallel
excursions of sorbitol with taurine in response to hyper-
glycemic concentrations of glucose were found to be qualita-
tively and quantitatively modulated by the regulation of the
AR gene (77). However, even under isosmotic euglycemic (5
mM glucose) conditions, overexpression of AR was associated
with decreased TT gene expression (80, 81). We now have ex-
tended these observations to explore the effect of AR gene ex-
pression on the response of the TT to oxidative stress. Oxida-
tive stress was found to increase TT gene expression, but this
induction was blunted in high AR-expressing cells. Moreover,
exposure of RPE cells to high glucose increased oxidative
stress, but down-regulated TT expression. These studies dem-
onstrate for the first time that the TT is regulated by oxidative
stress and that overexpression of AR and high glucose impair
this response. These studies offer mechanistic insight into the
role of abnormal AR gene expression in the development of
impaired antioxidant defense, which may determine tissue
susceptibility to chronic diabetic complications.
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MATERIALS AND METHODS
Materials
Cell culture media [minimum essential medium (MEM)]
([taurine] = 0 µM), Hanks’ balanced salt solution, and
Trypsin-EDTA and antibiotics were obtained from GIBCO
Inc. (Grand Island, NY, U.S.A.); bovine calf serum ([taurine]
= 80–120 µM) from Hyclone Laboratories (Logan, UT,
U.S.A.); culture dishes, wells, and flasks from Falcon (Lin-
coln Park, NJ, U.S.A.); bicinchoninic acid, copper sulfate
from Sigma Chemical Co. (St. Louis, MO, U.S.A.); and ra-
dioisotopes from Amersham (Arlington Heights, IL, U.S.A.).
Sorbinil was a gift from Pfizer Inc. (Groton, CT, U.S.A.), and
fidarestat was a gift from Sanwa Kagaku Kenkyusho Ltd.,
Co. (Nagoya, Japan). Values were normalized to cell protein
determined by the bicinchoninic acid method with bovine
serum albumin (BSA) as the standard.
Cell culture techniques and experimental design
Primary cultures of RPE cells were established as previ-
ously described (12) using postmortem eyes, obtained from
the Michigan Eye Bank. RPE cell lines were passaged at a
density of 40,000–100,000 cells/cm2 in 25-cm2 or 75-cm2
flasks in MEM with 2 mM L-glutamine containing 20%
bovine serum (BS) ([taurine] adjusted to 50 µM) and 5 mM
glucose at 37°C in a humidified 95% air/5% CO2 atmosphere.
Passaged cells were plated at initial densities of 5,000–20,000
cells/cm2 in six-well plates or 150-mm diameter culture
dishes to yield near-confluent cultures at the end of experi-
ments. The freshly plated cells were allowed to attach in stan-
dard growth medium for 24 h and then grown in MEM with
5% BS for 72 h at 37°C to allow equilibration to take place.
After 72 h, the cells were exposed to the various experimental
conditions specified in the text and figure legends, and bio-
chemical and molecular measurements were performed as de-
scribed below. The phenotypic characteristics were monitored
microscopically, functionally [rod outer segment phagocyto-
sis (12)], and immunocytochemically [acetoacetylated low-
density lipoprotein receptor protein (12)]. Neither cell
morphology nor survival was altered detectably by the experi-
mental conditions used in these studies.
Northern analysis techniques
Total cellular RNA was isolated and purified from cul-
tured RPE cells by differential extraction with acid phenol
(81) after exposure to various experimental conditions (see
below). Ten micrograms of RPE cell RNA or 2.5 µg of a
0.24–9.5-kb RNA ladder (Life Technologies, Gaithersburg,
MD, U.S.A.) was resolved on 2.2 M formaldehyde–1%
agarose gel and transferred by capillary blotting to nylon
membranes (Zetabind; Cuno Inc., Meridian, CT, U.S.A.).
Methylene blue staining confirmed uniformity of loading and
transfer and integrity of RNA, and the filters were fixed in
vacuo at 80°C for 2 h. Probes were labeled with [-32P]dCTP
using random primers to a specific activity in excess of 109
dpm/µg. Filters were prehybridized at 65°C in 0.5 M
NaH2PO4, pH 7.0, 1 mM EDTA, 7% sodium dodecyl sulfate
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(SDS), and 1% BSA (fraction V) for 4–6 h before denatured
probe was added. After 18 h, filters were washed twice with
40 mM NaH2PO4, pH 7.0, 1 mM EDTA, and 7% SDS at 65°C,
and four times with 40 mM NaH2PO4, pH 7.0, 1 mM EDTA,
and 1% SDS at 65°C. Hybridization was quantified using a
PhosphorImager (Molecular Dynamics Inc., Sunnyvale, CA,
U.S.A.) or by exposure at 80°C to preflashed X-Omat AR
(Kodak) film with intensifying screens, and multiple expo-
sures of the autoradiogram were obtained and quantitated by
laser densitometry. Filters were sequentially hybridized,
stripped, and rehybridized with 32P-labeled cDNA probes
for human AR (81), human taurine transporter (hTT) (81),
and glyceraldehyde-3-phosphate dehydrogenase (GAPDH)
mRNA as previously described (81).
Evaluation of TT transcriptional rate
Preparation of 4.6-kb hTT promoter DNA and
the reporter construct. A 4.6-kb TT genomic DNA
fragment extending upstream from the 5 end of exon 1 was
polymerase chain reaction (PCR)-amplified (Roche, Expand
long template system) from human genomic DNA isolated
from RPE cells using the following PCR primers: forward,
5-AGGCAGGCAAGAGGAGGGTAGTGG-3 reverse, 5-
CCCTCTTGGCGCAGCTTGTCCTCT-3. 5 XhoI and 3
BglII restriction sites were added to the forward and reverse
primers, respectively. The PCR product was TA-cloned into
PCR 2.1 (Invitrogen Corp., TA cloning kit), and sense and an-
tisense constructs were identified by restriction digests and
confirmed by DNA sequencing. The sense orientation frag-
ment was digested out of PCR 2.1 using KpnI/BglII and sub-
cloned into pGL3-Basic (Promega, Madison, WI, U.S.A.) for
transfection studies. Cloning success was confirmed by re-
striction digest and sequencing. RPE cells were seeded at
25,000 cells per well in 24-well cluster dishes and transfected
24 h post seeding with 180 ng of a 4.6-kb fragment of the TT
promoter region DNA cloned into the promoterless luciferase
vector pGL3-Basic (Promega). In order to standardize for
transfection efficiency, RPE cells were cotransfected with 5
ng of pRL-SV40 vector (Renilla reniformis luciferase re-
porter vector; Promega) using LipofectAMINE 2000 (Invitro-
gen Corp.). An empty pGL-Basic vector was used as a nega-
tive control. Cells were allowed to express transfected DNA
for 24 h, exposed to various experimental conditions, and
then harvested and lysed in 200 µl of lysis buffer, and the lu-
ciferase assay was performed using the Promega DLR system
and a luminometer. The promoter activity (in relative light
units) of the construct under various experimental conditions
was determined as the mean of three samples normalized to
the pRL-SV40 control.
Biochemical measurements
Measurement of sorbitol content. RPE cell sor-
bitol content was determined as previously described by
gas–liquid chromatography of aldonitrile acetate derivatives
from lyophilized aliquots of protein-free filtrates of RPE cells
sonicated in 5% (wt/vol) trichloroacetic acid with methyl -D-
mannopyranoside as an internal standard (77). Standard curves
were generated daily and the recovery-corrected values ex-
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pressed as nanomoles per milligram of protein. Cell protein
was measured by using bicinchoninic acid.
Measurement of malondialdehyde (MDA) pro-
duction. Analysis of MDA was performed using a commer-
cially available kit (Oxis International, Inc., Portland, OR,
U.S.A.; catalog no. MDA LPO 586). RPE cell cultures were
grown in 15-cm dishes to 80% confluency and treated under
experimental conditions. At time of harvest, cell cultures were
washed twice with phosphate-buffered saline (PBS), residual
PBS was removed by aspiration, and cells were trypsinized.
The cell pellet was collected by centrifugation (50  g, 10
min) and washed with PBS, and samples were stored at 80°C
until ready for analysis. Cell pellets were thawed and homoge-
nized in 100 µl of Tris (100 mM, pH 7) supplemented with 5
mM butylated hydroxytoluene using a glass Dounce homoge-
nizer. The homogenate was collected and centrifuged at 10,000
g (30 min, 4°C) to remove solid debris. Samples were then al-
lowed to react with the chromogen N-methyl-2-phenylindole (1
h, 45°C) and centrifuged. Supernatant absorbance was mea-
sured spectrophotometrically at 586 nm and compared with the
MDA standards processed in the same run.  Results were nor-
malized to protein content.
Cell taurine content. Taurine was measured by
reversed-phase HPLC after precolumn derivatization with 
o-phthalaldehyde (81). In brief, cells were sonicated in 1 ml of
6% trichloroacetic acid and centrifuged at 4,000 g for 10 min.
The supernatants were purified on washed dual-bed, ion-ex-
change columns [2.5 cm of AG 1-X8 100–200 mesh (Bio-Rad,
Richmond, CA, U.S.A.) in the chloride form over 2.5 cm of AG
50W-X8 200–400 mesh (Bio-Rad) in the hydrogen form] by
elution with 2 ml of water and lyophilized. Samples and stan-
dards were dissolved in 100 µl of water prior to HPLC analysis
on a Waters system (Waters, Milford, MA, U.S.A.) equipped
with a model 501 pump, a 717 autosampler, a 3.9  150 mm
Nova-Pak C18 column, and a model 470 scanning fluorescence
detector. Isocratic elution was carried out at a flow rate of 2
ml/min, using 43% solvent A (0.05 M NaH2PO4, pH 5.3, plus 5
M NaOH) combined with 57% solvent B (0.05 M NaH2PO4 in
75% methanol/water). Glutamine, added after ion-exchange
chromatography, was used as the internal standard. Standard
curves were linear over the concentration range in RPE sam-
ples, and recovery of taurine was >90%.
Taurine uptake. Cells were cultured in six-well plates
to reach 80% confluence, exposed to various experimental con-
ditions, and then washed three times in 2-ml aliquots of pre-
warmed (37°C) uptake buffer (20 mM HEPES, 140 mM NaCl,
5.4 mM KCl, 1.0 mM CaCl2, 0.8 mM MgSO4, and 5 mM glu-
cose) and equilibrated in 3 ml of the uptake buffer at 37°C. Up-
take was initiated by adding uptake buffer containing [14C]-
taurine (1 µM taurine and 0.1 µCi/ml). Aliquots of the original
labeled media were counted to determine specific activity. Up-
take was measured over 5 min (at which time uptake was lin-
ear). Na+-independent uptake was measured by substituting
NaCl with equimolar concentrations of choline chloride. The
radioactive buffer was aspirated and the cells washed in ice-
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cold uptake buffer in the absence of radioactive taurine, ex-
tracted at room temperature in 1 ml of 0.1 M NaOH, and soni-
cated; uptake was measured by scintillation spectrometry and
expressed as picomoles of taurine per milligram of protein per
minute. At 1 µM [14C]taurine, the Na+-independent component
was negligible (<1% of total uptake) and was not routinely
subtracted from total uptake for the measurement of Na+-
dependent uptake.
Preparation of TT polyclonal antibodies
The Michigan Diabetes Research and Training Center
Molecular Biology Core prepared recombinant hTT antigen
for the production of polyclonal antibodies. Synthetic pep-
tides were prepared using a hydrophilic antigenic C-terminal
sequence of the hTT, corresponding to amino acids 581–603
conjugated with heterobifunctional cross-linkers to both key-
hole limpet hemocyanin (KLH) and BSA. Rabbits were im-
munized with the KLH-conjugated antigens, and postimmu-
nization test sera obtained demonstrated substantial titer
(1:700,000). 
Western blot analysis
Human RPE cells were lysed in RIPA buffer (50 mM Tris-
HCl, 150 mM NaCl, 1 mM EGTA, 1% Nonidet P-40, 0.015%
sodium deoxycholate, 1 µg/ml aprotinin, leupeptin, and pep-
statin, and 1 mM phenylmethylsulfonyl fluoride). The lysates
were cleared by centrifugation at 14,000 g for 2 min and the
supernatants transferred to new tubes. Forty-microgram
aliquots of protein extract of RPE were separated by elec-
trophoresis on a 7.5% SDS–polyacrylamide gel and trans-
ferred to a polyvinylidene difluoride membrane. The blots
were blocked in 5% nonfat dry milk in Tris-buffered saline
for 1 h and subsequently incubated for 2 h at room tempera-
ture with the polyclonal rabbit anti-human TT antibody (di-
luted 1:3,000). After washing, the blots were incubated with
peroxidase-conjugated affinity-purified donkey anti-rabbit
IgG (Amersham Pharmacia Biotech, U.K.) at 1:1,000 for 1 h,
and the blots were analyzed with a luminol chemiluminescent
detection kit (Boehringer Mannheim Biological, Indianapo-
lis, IN, U.S.A.).
Statistical analysis
Data are expressed as means ± SE of at least three deter-
minations for a representative experiment. Each experiment
was replicated in triplicate. Differences among experimental
groups were detected by analysis of variance, and the differ-
ence between these groups was assessed by the Student–
Newman–Keuls test. Significance was defined at the 0.05 level.
RESULTS
Stable transfection of RPE cells to express human
AR at a high level
A cDNA library in pcDNAI was prepared from size-
selected (>1 kb) RNA extracted from hypertonicity-stressed
RPE cells. Screening with a partial human AR cDNA
(77) yielded multiple recombinant plasmids. Plasmids with 
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~1.3-kb inserts were selected for nucleotide sequencing
using primers flanking the insert to establish that the com-
plete open reading frame was present. Because of the vari-
able lengths of the 3 and 5 untranslated regions, plasmids
were screened for function by transiently transfecting COS
and RPE cells and measuring AR enzymatic activity (77). A
clone with the highest AR activity was selected for stable
transformation in low AR-expressing RPE 47 cells. After
lethal concentrations of G418 (neomycin) were determined
in this cell line, the cells were cotransfected with pRSV-
neo-pcDNA1-AR27, and 400 G418-resistant colonies were
isolated and screened for high AR gene expression by stimu-
lating with 300 mM glucose for 4 h and measuring sorbitol
content. This time period was sufficient for production of ex-
cess sorbitol in candidates overexpressing AR, but insuffi-
cient to osmotically stimulate transcription of the endoge-
nous gene (77). In the initial assessment of 98 of the
G418-resistant clones, four clones were identified that dem-
onstrated greatly elevated (>100-fold higher than untrans-
fected RPE 47 cells) sorbitol content. Three stably trans-
fected clones (designated numbers 72, 74, and 75) were then
evaluated for high levels of AR enzymatic activity. All three
of these stably transfected clones expressed fourfold ele-
vated AR enzymatic activity relative to untransfected RPE
47 cells (data not shown), and reproduced the basal AR ac-
tivity of untransfected naturally high AR-expressing RPE 91
cell line.
Expression of the AR gene in untransformed 
and stably transformed RPE cell lines
In order to compare AR gene expression in parental RPE
47 cells, AR-transformed RPE 75 cells, and naturally high
AR-expressing RPE 91 cells (27, 77), total cytoplasmic RNA
was extracted from cells exposed to 5 mM glucose for 24 h,
and northern blots were prepared, then sequentially hy-
bridized with a partial human AR cDNA, and normalized to
GAPDH. In RPE 75 cells, two AR transcripts were observed,
a 2.1-kb transcript consistent with the size predicted for the
transfected AR gene and a 1.4-kb transcript consistent with
expression of the endogenous AR gene (27, 77) (Fig. 1).
Basal expression of AR (transfected and endogenous AR
genes) gene was increased 3.5-fold versus the parental RPE
47 cells, which reproduced that observed in the naturally high
AR-expressing RPE 91 cells. In RPE 75 cells, basal expres-
sion of the endogenous AR gene was decreased, however, by
38% compared with that in the parental RPE 47 cells. These
data therefore suggest that the RPE 75 cell line reproduces
the high basal level of AR gene expression observed in the
RPE 91 cells. Moreover, in RPE 75 cells, down-regulation of
the endogenous AR gene suggests complex interactions
among osmoregulatory genes.
Molecular cloning of the TT promoter
A human peripheral blood leukocyte genomic DNA li-
brary was screened with a TT cDNA. Candidate clones were
hybridized with more 5 TT cDNAs, and positive clones were
purified. Large-scale phage DNA preparations were digested
with restriction endonucleases and mapped by Southern
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blotting. The 5 end of the first exon was confirmed by spe-
cific primer extension and nuclease protection experiments.
The structure of the full-length (4.6 kb) TT promoter is
shown in Fig. 2. The promoter contains an antioxidant re-
sponse element (ARE) (70) (GTGACNNNGC) at 1,349, as
well as two putative tonicity response elements (TonEs) at
576 and 770. Other sites potentially sensitive to glucose,
osmotic, or oxidative stress-mediated regulation include an
aryl-hydrocarbon receptor (AhR) (10 , 37 , 57), four nuclear
factor-B (NK-B) sites (44), an activator protein-1 (AP-1)
site (72) at 534, and a nuclear factor, erythroid derived 2
(NF-E2) site (59, 75, 88).
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TT gene expression in human RPE cells in
response to osmotic and oxidative stress
Effect of tonicity on regulation of the TT pro-
moter. Compared with the empty pGL-Basic vector, tran-
sient transfection of the TT promoter-driven reporter construct
into low AR-expressing RPE 47 cells demonstrated robust ac-
tivity, which was unaffected by AR inhibition (data not shown)
and increased threefold (p < 0.05) after exposure of the cells to
300 mM mannitol (Fig. 3). This induction of TT promoter ac-
tivity by 300 mM mannitol is consistent with the reported in-
crease in TT steady-state mRNA abundance under these condi-
FIG. 1. Expression of the AR gene in untransformed and
stably transformed RPE cell lines.
FIG. 2. A human peripheral blood leukocyte genomic DNA library was screened with a TT cDNA. Candidate clones were
hybridized with more 5 TT cDNAs, and positive clones were purified. Large-scale phage DNA preparations were digested with
restriction endonucleases and mapped by Southern blotting. The 5 end of the first exon was confirmed by specific primer exten-






























































FIG. 3. Low AR-expressing RPE 47 cells and high AR-
expressing RPE 75 cells were transiently transfected (using
LipofectAMINE reagent) with a full-length (4.6 kb) TT
promoter-luciferase fusion gene in conditions of 5 mM glu-
cose, and 24 h post transfection exposed to 300 mM manni-
tol (M) (for 16 h) or ARI (48 h) and luciferase activity mea-
sured. Data are shown as means ± SEM. *p < 0.05 versus
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tions. Transfection of the TT promoter construct into RPE 75
cells resulted in a down-regulation of TT promoter activity to
levels that were 46% (p < 0.05) lower than that measured in RPE
47 cells (Fig. 3). In RPE 75 cells, down-regulation of the TT pro-
moter could be prevented by incubation of the cells with an AR
inhibitor (ARI) [TT transcription increased by 48% (p = NS ver-
sus RPE 47 cells)] (Fig. 3). In concert, the levels of the TT
mRNA, TT peptide, and TT activity were decreased by 41%,
54%, and by 66% in RPE 75 cells, respectively (Fig. 4). These
decreases were also partially attenuated by the addition of ARI.
Sorbitol content was increased sevenfold in RPE 75 cells
(Fig. 5). Addition of an ARI lowered sorbitol content 96%
(p < 0.01) to levels that were not significantly different from
those of RPE 47 cells (data not shown). Consistent with the
decrease in TT gene transcription, steady-state mRNA level,
peptide abundance, and transporter activity, intracellular tau-
rine content was decreased by 36% in RPE 75 cells (Fig. 5).
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Addition of ARI increased levels of taurine by 20% (p <
0.05), with levels of intracellular taurine of ARI-treated RPE
75 cells remaining 25% (p < 0.05) below levels in RPE 47
cells. These data confirm osmotic regulation of the TT pro-
moter and that in high AR-expressing cells, intracellular sor-
bitol accumulation decreases TT transcriptional rate, protein
abundance, and activity.
Effect of oxidative stress on regulation of the TT
promoter. The effect of exposure of RPE 47 cells to a panel
of prooxidants on TT promoter regulation was initially explored
(Fig. 6). TT promoter transcriptional activity was increased up
to 900% by prooxidant exposure, which was associated with in-
creased TT peptide abundance (Fig. 6, inset) and taurine trans-
port (Fig. 7B). In comparison, however, induction of TT pro-
moter transcriptional activity by oxidative stress was attenuated




































































FIG. 4. (A) Northern blot analysis of TT mRNA abundance was performed on extracts from RPE 75 and 47 cells exposed to 5
mM glucose with and without 100 µM sorbinil for 72 h. Northern blots were prepared, then sequentially hybridized with the TT
cDNA probe, and normalized to GAPDH. The data shown are the means ± SEM of three different cell preparations. Statistical
comparison was performed on data from three independent experiments. *p < 0.05 versus RPE 47 cells. (B) Western blot analysis
of TT peptide abudance was performed on protein extracts from RPE 75 and 47 cells exposed to 5 mM glucose with and without
100 µM sorbinil for 72 h. The blots were probed sequentially with the polyclonal rabbit anti-hTT antibody or preimmune sera. A
69-kDa protein (the expected TT molecular mass) was detected by western blot analysis when RPE cell protein extracts were
probed with the TT antibody. (C) The effect of basal AR gene expression on TT Na+-dependent cotransporter activity was evalu-
ated after 72 h in RPE 75 and 47 cells exposed to 5 mM glucose with and without 100  µM sorbinil for 72 h. The data shown are
the means ± SEM of three different cell preparations. Statistical comparison was performed on data from three independent ex-
periments. *p < 0.05 versus RPE 47 cells; †p < 0.05 versus RPE 75 cells.
C.
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transport was unchanged (Fig. 7B). ARI cotreatment however,
restored up-regulation of TT promoter activity and taurine
transport in response to oxidative challenge.  These data demon-
strate for the first time that the TT is up-regulated by oxidative
stress and that AR overexpression impairs this response.
Effect of high glucose on MDA levels 
and TT promoter activity in RPE 75 cells
High glucose increases production of reactive oxygen
species (ROS) in high AR-expressing RPE cells (unpublished
observations). The effect of exposure of high AR-expressing
RPE 75 cells to 5 and 20 mM glucose for 48 h on MDA con-
tent was next explored. MDA content was increased 2.7-fold
(p < 0.05) under high-glucose conditions, consistent with
increased oxidative stress (Fig. 8A) [MDA levels in RPE 47
cells did not increase in 20 mM glucose (data not shown)].
However, despite increased oxidative stress, TT promoter ac-
tivity was down-regulated (Fig. 8B). Therefore, in high AR-
expressing cells, high-glucose exposure increases oxidative
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stress, but paradoxically down-regulates antioxidant defense
systems.
DISCUSSION
In diabetes, increased expression of AR has been impli-
cated as the critical link between chronic glucose toxicity and
tissue damage (6, 15, 36, 73, 79, 86). The precise pathophysi-
ological mechanisms whereby the reduction of glucose by AR
may predispose to the development of diabetic complications
is uncertain, but has been invoked to include depletion of the
osmolyte and antioxidant taurine (64, 67, 79, 80) through an
inhibitory effect on its Na+-dependent cotransporter (79–81).



























FIG. 5. Intracellular sorbitol and taurine contents were
evaluated after 72 h in RPE 75 and 47 cells maintained in 5
mM glucose. The data shown are the means ± SEM of three
different cell preparations. Statistical comparison was per-
formed on data from three independent experiments. *p < 0.05,
**p < 0.001 versus RPE 47 cells.
FIG. 6. RPE 47 cells were transiently transfected with the
full-length (4.6 kb) TT promoter-luciferase gene and 24 h
posttransfection exposed to the prooxidants hydrogen
peroxide (H2O2) (0.5 mM), primaquine (PQ) (50 µM),
artemisinin (ART) (50 µM), diethyl maleate (DEM)
(60 µM), and buthionine sulfoximine (BSO) (50 µM).
(Inset) Corresponding change in TT peptide abundance and
TT activity. Data are shown as means ± SEM. *p < 0.05 versus





























































FIG. 7. (A) RPE 75 cells were transiently transfected with the full-length (4.6 kb) TT promoter-luciferase gene and 24 h post
transfection exposed to the prooxidant primaquine (PQ) (50 µM). Data are shown as means ± SEM. *p < 0.05 versus basal RPE 47
activity. (B) The effect of basal AR gene expression on TT Na+-dependent cotransporter activity was evaluated after 24 h in RPE
75 cells exposed to the prooxidant primaquine (PQ) (50 µM) with or without ARI fidarestat. Data are shown as means ± SEM. *p
< 0.05 versus basal RPE 75 activity. The data shown are the mean ± SEM of three different cell preparations.
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stress and basal AR gene expression to TT gene expression,
protein abundance, and TT activity in low AR-expressing
human RPE 47 cells and RPE 47 cells stably transformed to
overexpress AR (designated RPE 75). In low AR-expressing
RPE 47 cells, the TT promoter demonstrated robust activity,
which was unaffected by ARI and increased threefold in hy-
pertonicity. In high AR-expressing RPE 75 cells, TT pro-
moter activity was decreased by 46% and this down-
regulation was prevented by an ARI. In low AR-expressing
cells, TT promoter activity increased up to 900% by prooxi-
dant exposure, which was associated with increased TT pep-
tide abundance. However, induction of TT promoter activity
by oxidative stress was attenuated in high AR-expressing
cells and partially corrected by ARI. High-glucose exposure
increased MDA production, but paradoxically down-
regulated TT transcription. These studies demonstrate that the
TT is up-regulated by oxidative stress and that overexpression
of AR and hyperglycemia impair this response. Glucose
metabolism by AR may therefore contribute to impaired
antioxidant defense, which may determine tissue susceptibil-
ity to chronic diabetic complications.
The recognition that AR gene expression is heterogeneous
not only between different tissues, but also between similar
cell lines, such as RPE cells isolated from different individu-
als, has expanded interest in understanding regulation of the
gene, not only in response to hypertonicity, but also under
isotonic conditions. AR gene expression and activity can
vary up to 10-fold under isotonic conditions in different RPE
cell lines (27, 77). The high basal level of AR gene expres-
sion and activity in the RPE 91 cell line, for example, can be
reproduced in other RPE cell lines only after maximal hyper-
tonic conditioning (27, 77). Such heterogeneous expression
of the AR gene may precondition the cell to glucose toxicity
in the presence of otherwise modest elevations of the ambi-
ent glucose level (79, 81) by activating ROS-producing path-
ways and by impairing antioxidant defense systems, includ-
ing taurine.
Primary cultures of RPE 47 cells were stably transformed
to overexpress AR.  The resultant RPE 75 cells in 5 mM glu-
cose achieved approximately fourfold elevation of basal AR
gene expression and approximately sevenfold elevation of in-
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tracellular sorbitol content, thereby reproducing the degree
of AR overexpression observed in the naturally AR-
overexpressing RPE 91 cell line (27, 81). Overexpression of
AR was found to have no demonstrable effects on cell viabil-
ity or growth characteristics (data not shown). However, ex-
pression of the TT in RPE 75 cells was found to be very sen-
sitive to intracellular sorbitol accumulation, because even in
5 mM glucose, TT gene expression, protein abundance, and
activity were decreased and levels of intracellular taurine re-
duced by ~40%. Therefore AR overexpression may increase
cellular susceptibility to glucose-derived oxidative damage,
because levels of the important endogenous antioxidant tau-
rine are depleted in response to small elevations of sorbitol-
derived intracellular tonicity.
The etiology of the down-regulation of TT in response to
alterations in intracellular osmotic stress is unclear. AR, as
well as other osmoregulatory genes, is transcriptionally up-
regulated by homologous TonEs in their 5 flanking sequence
(18, 25, 40, 69), which bind TonE binding proteins
(TonEBPs) in response to hypertonic stress (51, 87). Indeed,
molecular cloning of the TT promoter revealed two putative
TonEs, which may inhibit basal transcription in response to
small increases in sorbitol-derived intracellular osmotic
stress. TonEs have been shown to cooperatively interact in re-
sponse to hypertonic stress in the human AR gene (40). A
ubiquitous TonEBP cDNA has been cloned (51), which in-
creases fourfold in abundance in response to hypertonicity
(87). The DNA-binding domain of TonEBP is 45% homolo-
gous to the DNA-binding domains of the nuclear factor of ac-
tivated T-cell (NFAT) family of transcription factors, but un-
like NFAT, can stimulate transcription in the absence of
activation AP-1 (47). The TonEBP is phosphorylated at serine
and tyrosine residues in hypertonic conditions (9) and be-
comes localized within the nucleus within 12 h (51). The sig-
nal transduction pathways that are involved in the response to
hypertonic stress remain poorly characterized, but are thought
to involve the p38 kinase pathway (14, 55). The role of TonEs
and TonEBPs in the transcriptional response to hypotonic
stress is, however, much less clearly defined. In Madin–
Darby canine kidney cells, TonEBP abundance and nuclear








































FIG. 8. (A) RPE 75 cells were exposed to 5 or 20 mM glucose for 48 h. Total MDA content was assessed using a commercially
available kit from Oxis International Inc. Data are shown as means ± SEM. *p < 0.05 versus basal RPE 75 basal. (B) RPE 75 cells
were transiently transfected with the full-length (4.6 kb) TT promoter-luciferase gene and 24 h post transfection exposed to 5 or
20 mM glucose for 48 h. Data are shown as means + SEM. *p < 0.05 versus mM glucose.
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tonicity, implicating tonic activation of TonEBP under iso-
tonic conditions. Presumably, if transcriptional regulation of
the TT involves similar TonEs and TonEBPs identified in
other osmoregulated genes, this regulatory pathway appears
to be highly sensitive to alterations in intracellular tonicity,
making it uniquely sensitive to disruption by AR overexpres-
sion or elevated glucose. The precise mechanisms whereby
AR overexpression down-regulates TT gene expression re-
main to be explored.
Prooxidant exposure dramatically increased TT transcrip-
tion and peptide synthesis, consistent with an important role
for taurine in the cell antioxidant defense. Analysis of
the promoter region of the TT revealed an ARE (5-
TGACTCGGC-3), which is known to mediate transcrip-
tional activation of genes in cells exposed to oxidative stress
(59). These genes include those important in the regulation
of cellular redox and the protection from oxidative damage,
including glutathione S-transferases (19), –glutamylcys-
teine transferase catalytic and regulatory subunits (53),
NAD(P)H:quinone oxidoreductase (46), and heme oxyge-
nase-1 (32). Although the regulation of the ARE is not well
understood, it is thought to involve a class of transcription
factors known as bZIP (basic region plus leucine zipper)
proteins, which bind to DNA as part of a homodimer and/or
heterodimer complex (59). Indeed, the bZIP transcription
factor NF-E2-related factor 2 (Nrf2) mediates ARE-driven
response to oxidative stress (30, 88) and has been shown to
be important in the transcriptional activation of many genes
regulated by oxidative stress (1, 58, 85). It is thought that
Nrf2 may mediate both basal and inducible activity of the
ARE (49). Nrfs may heterodimerize with small Maf proteins
(16), which can act as transcriptional repressors (16). Fi-
nally, Nrf2 activity can be repressed by association with
Kelch-like-ECH-associated protein 1 (Keap 1), which is
thought to prevent Nrf2 nuclear translocation (59).
The complex regulation of the ARE and the importance of
its context, outside its core sequence (59), make it highly sus-
ceptible to alterations in the intracellular milieu, as might
occur in response to overexpression of AR and/or the pres-
ence of hyperglycemia. For example, nuclear translocation of
Nrf2 may be regulated by glucose- and insulin-sensitive sig-
nal transduction pathways, including protein kinase C (PKC)
(29) and phosphatidylinositol 3-kinase. PKC, for example,
has been shown to activate the ARE in an Nrf2-dependent
manner by direct phosphorylation, thereby stimulating
translocation from the cytoplasm to the nucleus (29). In RPE
cells, PKC activation increases TT gene transcription (81)
and overexpression of AR has been associated with down-
regulation of PKC (56), which may therefore influence both
basal and inducible ARE activity. The role of the mitogen-
activated protein kinase cascades in the regulation of the ARE
has also been extensively evaluated, although remains poorly
understood. In general, activation of the extracellular regu-
lated kinase pathway has been positively associated with acti-
vation of the ARE (88), whereas activation of p38 has been
associated with down-regulation of both basal and inducible
ARE activity (88). Whether tonicity-mediated activation of
the p38 kinase pathway (14, 55) is involved in the down-
regulation of basal and oxidative stress-inducible activation
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of the TT is currently being explored. Finally, the context of
the ARE in the TT may also play an important role in its regu-
lation, because the TT promoter contains a number of regula-
tory sequences known to be important in regulating gene ex-
pression in response to oxidative stress, including AP-1 (68),
SP1 (71), NF-B (44) sites, as well as TonEs (40, 43). Explo-
ration of the potential interactions between the ARE and these
sites may help elucidate the mechanisms contributing to aber-
rant regulation of the TT. 
Overexpression of AR and increased sorbitol pathway flux
have been linked to the development of diabetic complica-
tions (6, 15, 24, 36, 73, 75, 76, 79, 86). Increased AR gene
expression has been identified in peripheral blood mononu-
clear cells in diabetic patients with nephropathy (73) and mi-
crovascular complications (76). Increased AR immunoreac-
tivity has been identified in renal glomeruli and peripheral
nerve in postmortem specimens from diabetic patients and
correlated with the severity of the pathological changes (36).
The concept that aberrant overexpression of the AR gene may
predispose to the development of diabetic complications has
received support by the identification of polymorphisms at
the 5 end of the AR gene that are associated with the pres-
ence of microvascular complications in certain populations of
diabetic subjects (13, 20, 26, 35, 39, 73). In RPE cells, recent
studies have shown that AR gene transcription paralleled AR
mRNA abundance and activity, implicating increased AR
gene transcription as the basis of AR overexpression in high
AR-expressing tissues and cells (80, 81). Additionally, patho-
physiological elevations of glucose have been reported to in-
crease AR mRNA and protein abundance in RPE cells (28).
An association between an (A-C)n dinucleotide repeat in the
AR gene basal promoter region has been identified in dia-
betic subjects with nephropathy (73), retinopathy (20, 35,
39), and neuropathy (26) and with increased expression of the
AR gene (74). However, this association has been challenged
(17, 33), which may reflect heterogeneity in different ethnic
populations studied as well as the type of diabetes. More re-
cently, a C(106)T substitution in the AR gene basal pro-
moter has also been associated with nephropathy (52) and
retinopathy (13, 35). In any event in diabetes, overexpression
of AR irrespective of the mechanism increases the formation
of ROS (61) and impairs antioxidant defense systems such as
the TT, thereby predisposing to glucose toxicity.
In summary, these studies demonstrate that the TT is regu-
lated by oxidative stress and that overexpression of AR and hy-
perglycemia impair this response. Abnormal expression of AR
may therefore impair antioxidant defense, which may deter-
mine tissue susceptibility to chronic diabetic complications.
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ABBREVIATIONS
AhR, aryl-hydrocarbon receptor; AP-1, activator protein-
1; AR, aldose reductase; ARE, antioxidant response element;
ARI, aldose reductase inhibitor; BS, bovine serum; BSA,
bovine serum albumin; bZIP, basic region plus leucine zipper;
G418, neomycin; GAPDH, glyceraldehyde-3-phosphate
dehydrogenase; GSH, glutathione, reduced form; GSSG, glu-
tathione disulfide, oxidized form; hTT, human taurine trans-
porter; KLH, keyhole limpet hemocyanin; MDA, malon-
dialdehyde; MEM, minimum essential medium; NFAT,
nuclear factor of activated T-cell; NF-B, nuclear factor-B;
NF-E2, nuclear factor, erythroid derived 2; Nrf2, NF-E2-
related factor 2; PBS, phosphate-buffered saline; PCR, poly-
merase chain reaction; PKC, protein kinase C; ROS, reactive
oxygen species; RPE, retinal pigment epithelial; RPE 47,
retinal pigment epithelial cell clone no. 47; RPE 75, retinal
pigment epithelial cell clone no. 75; SDS, sodium dodecyl
sulfate; TonE, tonicity response element; TonEBP, TonE bind-
ing protein; TT, Na+-taurine cotransporter.
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